These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37988195)

  • 41. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 42. A composite score based on immune-related gene prognostic index and m
    Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z
    Front Genet; 2023; 14():1061569. PubMed ID: 36845378
    [No Abstract]   [Full Text] [Related]  

  • 43. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma.
    Zhang X; Jin L; Zhou C; Liu J; Jiang Q
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38504568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signature Based on Six Autophagy-related Genes to Predict Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhang H; Zhang L; Fan YT; Li TN; Peng LS; Wang KP; Ma J
    Curr Med Sci; 2022 Jun; 42(3):597-605. PubMed ID: 35648284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma.
    Zhang D; Zhao Y
    Front Genet; 2023; 14():1156230. PubMed ID: 37091780
    [No Abstract]   [Full Text] [Related]  

  • 50. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories.
    Yin J; Zheng S; He X; Huang Y; Hu L; Qin F; Zhong L; Li S; Hu W; Zhu J
    Sci Rep; 2022 Nov; 12(1):20404. PubMed ID: 36437265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarker Potential of
    Ju Y; Zhu F; Fang B
    Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.
    Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J
    J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying and Validating an Angiogenesis-related Signature for the Prognosis of Head and Neck Squamous Cell Carcinoma.
    Hou Y; Pang H; Xu X; Zhao D
    Curr Med Chem; 2024 May; ():. PubMed ID: 38752633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.
    Khorani K; Schwaerzler J; Burkart S; Kurth I; Holzinger D; Flechtenmacher C; Plinkert PK; Zaoui K; Hess J
    Mol Cancer Res; 2021 Oct; 19(10):1676-1687. PubMed ID: 34285085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
    Zhong Q; Zhou L; Zhu D
    J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
    Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
    Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.